Preliminary report: inhibition of cellular proteasome activity by free fatty acids

Metabolism: Clinical and Experimental

Volumn 58, Issue 8, 2009, Pages 1047-1049

  Hamel, Frederick G ^a,b,c  

^a VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMOTRYPSIN; FATTY ACID DERIVATIVE; INSULINASE; LINOLEIC ACID; OCTANOIC ACID; OLEIC ACID; PROTEASOME;

ARTICLE; CELL MEMBRANE PERMEABILITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION;

CELL LINE, TUMOR; CHYMOTRYPSIN; FATTY ACIDS, NONESTERIFIED; HUMANS; INHIBITORY CONCENTRATION 50; INSULYSIN; LINOLEIC ACID; OLEIC ACID; PROTEASOME ENDOPEPTIDASE COMPLEX; TRYPSIN;

EID: 67651114144     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.04.005     Document Type: Article

References (16)

1. Randle P.J., Garland P.B., Hales C.N., and Newsholme E.A. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1 (1963) 785-789
2. Sohal P.S., Baracos V.E., and Clandinin M.T. Dietary omega 3 fatty acid alters prostaglandin synthesis, glucose transport and protein turnover in skeletal muscle of healthy and diabetic rats. Biochem J 286 Pt 2 (1992) 405-411
3. Tessari P., Nissen S.L., Miles J.M., and Haymond M.W. Inverse relationship of leucine flux and oxidation to free fatty acid availability in vivo. J Clin Invest 77 (1986) 575-581
4. Fery F., Plat L., Baleriaux M., and Balasse E.O. Inhibition of lipolysis stimulates whole body glucose production and disposal in normal postabsorptive subjects. J Clin Endocrinol Metab 82 (1997) 825-830
5. Fery F., Plat L., Melot C., and Balasse E.O. Role of fat-derived substrates in the regulation of gluconeogenesis during fasting. Am J Physiol 270 5 Pt 1 (1996) E822-E830
6. Norrelund H., Nair K.S., Nielsen S., Frystyk J., Ivarsen P., Jorgensen J.O., et al. The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormone. J Clin Endocrinol Metab 88 (2003) 4371-4378
7. Bresson J.L., Bader B., Rocchiccioli F., Mariotti A., Ricour C., Sachs C., et al. Protein-metabolism kinetics and energy-substrate utilization in infants fed parenteral solutions with different glucose-fat ratios. Am J Clin Nutr 54 (1991) 370-376
8. Goldberg A.L. Functions of the proteasome: from protein degradation and immune surveillance to cancer therapy. Biochem Soc Trans 35 Pt 1 (2007) 12-17
9. Jariel-Encontre I., Bossis G., and Piechaczyk M. Ubiquitin-independent degradation of proteins by the proteasome. Biochim Biophys Acta 1786 (2008) 153-177
10. Jung T., and Grune T. The proteasome and its role in the degradation of oxidized proteins. IUBMB Life 60 (2008) 743-752
11. Bennett R.G., Hamel F.G., and Duckworth W.C. Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complex. Diabetes 46 (1997) 197-203
12. Bennett R.G., Hamel F.G., and Duckworth W.C. Insulin inhibits the ubiquitin-dependent degrading activity of the 26S proteasome. Endocrinology 141 (2000) 2508-2517
13. Duckworth W.C., Bennett R.G., and Hamel F.G. A direct inhibitory effect of insulin on a cytosolic proteolytic complex containing insulin-degrading enzyme and multicatalytic proteinase. J Biol Chem 269 (1994) 24575-24580
14. Duckworth W.C., Bennett R.G., and Hamel F.G. Insulin acts intracellularly on proteasomes through insulin-degrading enzyme. Biochem Biophys Res Commun 244 (1998) 390-394
15. Hamel F.G., Bennett R.G., Harmon K.S., and Duckworth W.C. Insulin inhibition of proteasome activity in intact cells. Biochem Biophys Res Commun 234 (1997) 671-674
16. Hamel F.G., Upward J.L., and Bennett R.G. In vitro inhibition of insulin-degrading enzyme by long-chain fatty acids and their coenzyme A thioesters. Endocrinology 144 (2003) 2404-2408